Asset management

As inflows soar and market dislocations vanish, an industry that consigned to history two major disruptions of the pandemic crash is back.

As asset managers launch funds with this new structure, lack of familiarity may hinder advisors’ adoption of them.

While small deals are likely, CEO James Gorman said he’d be reluctant to take on a large-scale acquisition

How the Fed proceeds is key for investors who have plowed into steepening bets, a move that peaked with last week’s surge in 10- and 30-year yields.

“The idea is economic fairness, economic justice, economic inclusion. Not just making donations,” says Ariel Investments co-CEO John Rogers.

The firm's new suite of eight low-cost ETFs include two funds that are no-fee.

Don’t expect significant changes anytime soon to longstanding complaints about conflicts of interest in the “issuer pay” model of the ratings business.

The firm joins a growing number of asset managers offering hidden-asset products.

As big banks adopt off-the-rack approaches to reopening skyscrapers to armies of employees, the asset management industry’s solutions are much more bespoke.

One French trade group reports that the country’s managers reduced research budgets by as much as 75% between 2017 and 2019.

Despite recent upheaval, some clients will still be shocked their portfolios have shown declines.

With return targets growing ever more elusive, many investors are willing to take their chances with private debt and equity.

The pandemic has sealed the fate of small, niche offerings that have failed to gain traction.

The purchase comes as active asset managers feel intensifying pressure to bulk up as they face stiff competition from passive and index-tracking funds.

The combined fund, expected to finalize later this year, will retain the Windsor name and continue to focus on large- and mid-cap value stocks.

Even some of the industry’s cheapest products “may be overpriced” in that they’re “mirroring a passive index,” an expert says.

As policymakers fear a deflation spiral reminiscent of the Great Depression, contrarians wonder if ultra-loose monetary policies can inspire growth.

It’s the latest example of how firms who spent the past decade battling low yields are now raising cash to seize on deep discounts from the coronavirus.

This year’s honorees discuss how their firms are coping with the coronavirus pandemic and how this period may reshape the industry.

Hedge fund managers, market academics and risk experts are channeling their data-mining smarts to the world of clinical sciences.